Job Watch

Publication of the Revised NIH Grants Policy Statement (Rev. October 2017) for FY 2018

Notice NOT-OD-18-005 from the NIH Guide for Grants and Contracts

Guidance on Exceptions to the NIH Single IRB Policy

Notice NOT-OD-18-003 from the NIH Guide for Grants and Contracts

Data Scientist, Natural Language Processing - KPMG - Atlanta, GA

Indeed.com - Bioinformatics - Wed, 2017-10-11 04:28
Build document clustering, topic analysis, text classification, named entity recognition, sentiment analysis, and part-of-speech tagging methods for...
From KPMG LLP - Wed, 11 Oct 2017 08:28:44 GMT - View all Atlanta, GA jobs
Categories: Job Watch

Data Scientist - KPMG - Atlanta, GA

Indeed.com - Bioinformatics - Wed, 2017-10-11 04:28
Perform machine learning, natural language, and statistical analysis methods, such as classification, collaborative filtering, association rules, sentiment...
From KPMG LLP - Wed, 11 Oct 2017 08:28:40 GMT - View all Atlanta, GA jobs
Categories: Job Watch

Postdoctoral Scholar - Penn State University - University Park, PA

Indeed.com - Bioinformatics - Tue, 2017-10-10 14:00
To apply, please submit a letter of application describing research interests and professional goals, as well as a CV and contact information for three...
From Penn State University - Tue, 10 Oct 2017 18:00:19 GMT - View all University Park, PA jobs
Categories: Job Watch

Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01)

Funding Opportunity RFA-CA-17-046 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, this FOA targets the following area designated as scientific priority by the Blue Ribbon Panel (BRP): Recommendation B. Create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers. The goal of the network is to foster collaborative team science approaches to accelerate the discover of new immune targets and evaluate novel immune-based therapies and combination approaches that eliminate established cancers in adults or to prevent cancers before they occur.

Immuno-Oncology Translation Network (IOTN): Data Management and Resource-Sharing Center (DMRC) (U24)

Funding Opportunity RFA-CA-17-047 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, this FOA targets the following area designated as scientific priority by the Blue Ribbon Panel (BRP): Recommendation B. Create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers. The goal of the network is to foster collaborative team science approaches to accelerate the discover of new immune targets and evaluate novel immune-based therapies and combination approaches that eliminate established cancers in adults or to prevent cancers before they occur.

Immuno-Oncology Translation Network (IOTN): Cellular Immunotherapy Data Resource (CIDR) (U24)

Funding Opportunity RFA-CA-17-048 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, this FOA targets the following area designated as scientific priority by the Blue Ribbon Panel (BRP): Recommendation B. Create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers. The goal of the network is to foster collaborative team science approaches to accelerate the discover of new immune targets and evaluate novel immune-based therapies and combination approaches that eliminate established cancers in adults or to prevent cancers before they occur.

Immuno-Oncology Translational Network (IOTN): Cancer Immunotherapy Research Projects (U01)

Funding Opportunity RFA-CA-17-045 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. Specifically, this FOA targets the following area designated as scientific priority by the Blue Ribbon Panel (BRP): Recommendation B. Create a translational science network devoted exclusively to immunotherapy approaches to treat and prevent adult cancers. The goal of the network is to foster collaborative team science approaches to accelerate the discover of new immune targets and evaluate novel immune-based therapies and combination approaches that eliminate established cancers in adults or to prevent cancers before they occur.

Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)

Funding Opportunity PAR-17-306 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to fund highly innovative and promising research that tests multi-level physical activity intervention programs acting on at least two levels of the socio-ecological model and designed to increase health-enhancing physical activity: 1) in persons or groups that can benefit from such activity; and 2) that could be made scalable and sustainable for broad use across the nation. This FOA provides support for up to 5 years for research planning, intervention delivery, and follow-up activities.

Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)

Funding Opportunity PAR-18-307 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to fund highly innovative and promising research aimed at developing multi-level physical activity intervention programs acting on at least two levels of the socioecological model and designed to increase health-enhancing physical activity: 1) in persons or groups that can benefit from such activity; and 2) that could be made scalable and sustainable for broad use across the nation. This FOA provides support for up to two years (R21 phase) for research planning activities and feasibility studies, followed by a possible transition to expanded research support (R33 phase) for optimizing the intervention and conducting larger-scale feasibility studies. Transition to the R33 depends on the completion of applicant-defined milestones, as well as program priorities and the availability of funds.

Limited Competition: Brain Tissue Resource Center for Alcohol Research (R28)

Funding Opportunity PAR-17-305 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) issued by the National Institute on Alcoholism and Alcohol Abuse (NIAAA), National Institutes of Health, is a limited competition FOA encouraging a resource project (R28) application from a center currently supported under an existing grant, entitled Brain Tissue Resource Center for Alcohol Research to (i) develop a bank of brain tissues (fresh-frozen and formalin-fixed) from alcoholic and control cases with confirmed clinical and pathological diagnoses, (ii) develop and promote a prospective brain donor program in Australia (Using our Brains) to enhance the brain bank, (iii) establish an associated DNA (blood) bank from the brain donor group, and (iv) invite research groups with an interest in alcohol-related brain damage to submit applications for studies using these tissues.

Pages

Subscribe to Anil Jegga aggregator - Job Watch